Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:48.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:11.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0; removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:34.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updated the site revision tag to v3.4.3 and removed the previous v3.4.2 reference.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:48.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:44:38.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this internal version change does not alter user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-02-04T22:57:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.